PATENT CLAIM ANALYSIS

Application Number: 16166611
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "252140"]

Abstract:
Disclosed herein are compounds that are inhibitors of BRD4 and their use in the treatment of cancer. Methods of screening for selective inhibitors of BRD4 are also disclosed. In certain aspects, disclosed are compounds of Formula I-IV.

Claim (Index 14):
The compound of  claim 4 , wherein R 2  is C 1-8  alkyl or heteroalkyl.

Metadata:
- Claim Count in Document: 113.0
- Percentile: 97.0
- Lexical Diversity: 1.46429
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15501613', '15619671', '14204076', '15531204', '15808421']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7414952811619371
- 35 USC 102 Novelty (BERT): 0.5564864265904389
- Combined Prediction Score: 0.7229943957047873
- Mean Citation Score: 335.640756
- Max Citation Score: 425.55173
- Similarity Product: 282.818261751842

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test